The mechanism connecting the BRAF mutation and aberrant methylation of promoter CGIs remains unclear, and the importance of this mutation to predict prognosis was not proven in recent larger studies involving >1,000 CRC patients (27,40). This evidence concerns the gene BRAF and colorectal carcinoma.